Overview
Acute Treatment of Bipolar II Depression
Status:
Completed
Completed
Trial end date:
2007-10-01
2007-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will compare the medications lithium and lamotrigine (Lamictal®) in treating depression in individuals with bipolar II disorder.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Stanford UniversityCollaborator:
National Institute of Mental Health (NIMH)Treatments:
Anticonvulsants
Lamotrigine
Lithium Carbonate
Criteria
Inclusion Criteria:- Current diagnosis of bipolar II disorder
Exclusion Criteria:
- Use of lithium or lamotrigine
- Intolerance to lithium or lamotrigine
- Substance abuse or dependence within the last month
- Suicidal thoughts
- Unstable medical conditions
- Pregnancy or breast-feeding
- Stable on current medications
- Use of fluoxetine (Prozac) within 2 weeks of study
- Require an antipsychotic medication
- Do not speak or read English